Inflammatory mechanism in ischemic neuronal injury

Neuroscience Bulletin

Volumn 22, Issue 3, 2006, Pages 171-182

  Wen, Ya Dan ^a   Zhang, Hui Ling ^a   Qin, Zheng Hong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Astrocytes; Cell adhesion molecules; Inflammation; Ischemic stroke; Leukocytes; Microglia; NF B

Indexed keywords

ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; CYCLOHEXIMIDE; CYTOKINE; DIZOCILPINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUTAMATE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOCYTE ANTIBODY; NEUTROPHIL INHIBITORY FACTOR; PADGEM PROTEIN; RECEPTOR BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELL ADHESION; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CHEMOTAXIS; ENDOTHELIUM; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MACROPHAGE; MICROGLIA; MONOCYTE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; POLYMORPHONUCLEAR CELL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; STROKE; UPREGULATION;

EID: 33847772577     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996, 137: 69-78.
2. Clark WM. Cytokines and reperfusion injury. Neurology 1997, 49 (Suppl 4): 10-14.
3. Ulrich D, Costantino I, Michael AM. Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 1999, 22, 391-397.
4. Okamoto M, Matsumoto M, Ohtsuki T, et al. Internucleosomal DNA cleavage involved in ischemia-induced neuronal death. Biochem Biophys Res Commun 1993, 196: 1356-1362.
5. Ferrer I, Tortosa A, Macaya A, et al. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994, 4: 115-122.
6. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993, 24: 2002-2009.
7. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 2000, 301: 173-187.
8. Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A, et al. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity. Trends Neurosci 1996, 19: 109-114.
9. Li Y, Chopp M, Jiang N, et al. Temporal profile of in situ fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995, 15: 389-397.
10. Li Y, Sharov VG, Jiang N, et al. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 1995, 146: 1045-1051.
11. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119: 493-501.
12. Braun JS, Jander S, Schroeter M, et al. Spatiote mporal relationship of apoptotic cell death to lymphomonocytic infiltration in photochemically induced focal ischemia of the rat cerebral cortex. Acta Neuropathol (Berl) 1996, 92: 255-263.
13. Bursch W, Paffe S, Putz B, et al. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990, 11: 847-853.
14. Majno G, Joris I. Apoptosis, oncosts, and necrosis. An overview of cell death. Am J Pathol 1995, 146: 3-15.
15. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267: 1456-1462.
16. Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischemic stroke patients and correlates with the volume of evolving brain infarct. Biomed Pharmacother 2001, 55: 258-263.
17. Kumar A, Takada Y, Boriek AM, et al. Nuclear factor-kappaB: its role in health and disease. J Mol Med 2004, 82: 434-448.
18. Moro MA, Almeida A, Bolanos JP, et al. Mitochondrial respiratory chain and free radical generation in stroke. Free Radical Biology and Medicine 2005, 39: 1291-1304.
19. Alexander M, Forster C, Sugimoto K, et al. Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans. Acta Neuropathol(Berl) 2003, 105: 420-424.
20. Suzuki S, Tanaka K, Nogawa S, et al. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp Neurol 2001, 170: 63-71.
21. Hill JK, Gunion-Rinker L, Kulhanek D, et al. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 1999, 820: 45-54.
22. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996, 137: 69-78.
23. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998, 56: 149-171.
24. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283: R7-R28.
25. Garcia JH, Liu KF, Yoshida Y, et al. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144: 188-199.
26. Yamasaki Y, Matsuo Y, Matsuura N, et al. Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke 1995, 26: 318-323.
27. Jander S, Kraemer M, Schroeter M, et al. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995, 15: 42-51.
28. Schroeter M, Jander S, Witte OW, et al. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 1994, 55: 195-203.
29. George R, Grilffin JW. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 1994, 129: 225-236.
30. Flaris NA, Densmore TL, Molleston MC, et al. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 1993, 7: 34-40.
31. Kim JS, Gautam SC, Chopp M, et al. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 1995, 56: 127-134.
32. Gourmala NG, Buttini M, Limonta S, et al. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 1997, 74: 35-44.
33. + macrophages/microglia. Eur J Neurosci 1998, 10: 680-688.
34. Hirji N, Lin TJ, Befus AD. A novel CD8 molecule expressed by alveolar and peritoneal macrophages stimulates nitric oxide production. J Immunol 1997, 158: 1833-1840.
35. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997, 20: 132-139.
36. Bidmon HJ, Wu J, Buchkremer-Ratzmann I, et al. Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions. Neuroscience 1998, 82: 377-395.
37. Wang X, Yue TL, Barone FC, et al. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 1995, 26: 661-666.
38. Kato H, Kogure K, Liu XH, et al. Progressive expression of immunomolecules on activated microglia and invading leukocytes following focal cerebral ischemia in the rat. Brain Res 1996, 734: 203-212.
39. Lehrmann E, Christensen T, Zimmer J, et al. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J Comp Neurol 1997, 386: 461-476.
40. Clark RK, Lee EV, White RF, et al. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 1994, 35: 387-392.
41. Clark WM, Zivin JA. Antileukocyte adhesion therapy: preclinical trials and combination therapy. Neurology 1997, 49 (5 suppl 4):S32-S38.
42. Cannella B, Cross AH, Raine CS. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 1990, 172: 1521-1524.
43. McGilvray ID, Lu Z, Bitar R, et al. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J Biol Chem 1997, 272: 10287-10294.
44. Eddleston M, de la Torre JC, Oldstone MB, et al. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest 1993, 92: 349-358.
45. Zhang ZG, Chopp M, Tang WX, et al. Postischemic treatment (2-4h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2h) focal cerebral ischemia in the rat. Brain Res 1995, 698: 79-85.
46. Chopp M, Li Y, Jiang N, et al. Antibodies against adhesion molecules reduce apoptosis after middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996, 16: 578-584.
47. Clark WM, Lauten JD, Lessov N, et al. The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats. J Mol Neurosci 1995, 6: 43-50.
48. Zhang RL, Chopp M, Li Y, et al. Anti-ICAM-1 antibody reduces ischemic cell damage after transient but not permanent MCA occlusion in the rat. Neurology 1994, 44:1747-1751
49. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19: 312-318.
50. Yenari MA, Giffard RG. Ischemic vulnerability of primary murine microglial cultures. Neurosci Lett 2001, 298: 5-8.
51. Flaris NA, Densmore TL, Molleston MC, et al. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 1993, 7: 34-40.
52. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290: 1768-1771.
53. Zhang Z, Chopp M, Powers C. Temporal profile of microglial response following transient (2h) middle cerebral artery occlusion. Brain Res 1997, 744: 189-198.
54. Fisher HG, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001, 166: 2717-2726.
55. Ridet JL, Malhotra SK, Privat A, et al. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997, 20: 570-577.
56. Smith GM, Hale JH. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 1997, 17: 9624-9633.
57. Schroeter M, Schiene K, Kraemer M, et al. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain Res 1995, 106: 1-6.
58. Yamashita K, Vogel P, Fritze K, et al. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Res 1996: 735: 285-297.
59. Yamada K, Goto S, Oyama T, et al. In vivo induction of the growth associated protein GAP43/B-50 in rat astrocytes following transient middle cerebral artery occlusion. Acta Neuropathol (Berl) 1994, 88: 553-557.
60. Lee TH, Kato H, Kogure K, et al. Temporal profile of nerve growth factor like immunoreactivity after transient focal cerebral ischemia in rats. Brain Res 1996, 713: 199-210.
61. Ghosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16: 225-260.
62. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18: 6853-6866.
63. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2: 725-734.
64. Senftleben U, Karin M. The IKK/NF-kappa B pathway. Crit Care Med 2002, 30 (1 Suppl): S18-S26.
65. Silverman N, Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001, 15: 2321-2342.
66. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol, 2000, 12: 85-98.
67. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3: 221-227.
68. Kumar A, Lnu S, Malya R, et al. Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen activated protein kinases in lung parenchyma: implications in asthma. FASEB J 2003, 17: 1800-1811.
69. Kumar A, Boriek AM. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 2003, 17: 386-396.
70. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002, 3: 20-26.
71. Wilkinson KD. Signal transduction: aspirin, ubiquitin and cancer. Nature 2003, 424: 738-739.
72. Nakai M, Qin ZH, Wang Y, et al. Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum. Brain Res Mol Brain Res 1999, 64: 59-68.
73. Qin Z, Wang Y, Chasea TN. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-Methyl-D-aspartate receptors in rat striatum. Brain Res Mol Brain Res 2000, 80: 111-122.
74. Schutze S, Potthoff K, Machleidt T, et al. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992, 71: 765-776.
75. Qin ZH, Chen RW, Wang Y, et al. Nuclear factor kappaB nuclear translocation up-regulates c-Myc and p53 during NMDA receptor-mediated apoptosis. J Neurosci 1999, 19: 4023-4033.
76. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995, 21: 195-218.
77. Grilli M, Memo M. Transcriptional pharmacology of neurodegenerative disorders: Novel venue towards neuroprotection against excitotoxicity? Mol Psychiatry 1997, 2: 192-194.
78. Liu T, McDonnell PC, Young PR. Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke 1993, 24: 1746-1751.
79. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994, 25: 1481-1488.
80. Wang X, Yue TL, Young PR, et al. Expression of interleukin-6, c-fos and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 1995, 15: 166-171.
81. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha, a mediator of focal ischemic brain injury. Stroke 1997, 28: 1233-1244.
82. Yamasaki Y, Matsuura N, Shozuhara H, et al. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26: 676-681.
83. Beamer NB, Coull BM, Clark WM, et al. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995, 37: 800-805.
84. Kim JS, Yoon SS, Kim YH, et al. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996, 27: 1553-1557.
85. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin 6 predicts the size of brain lesion in stroke. Stroke 1995, 26: 1393-1398.
86. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999, 1: 3-19.
87. Rothwell NJ, Loddick SA, Stroemer P. Interleukins and cerebral ischaemia. Int Rev Neurobiol 1997, 40: 281-298.
88. Taniguchi Y, Yorioka N, Oda H, et al. Platelet derived growth factor, interleukin (IL)-1 beta, IL-6, IL-6R and tumor necrosis factor-alpha in IgA nephropathy: an immunohistochemical study. Nephron 1996, 74: 652-660.
89. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994, 15: 74-80.
90. Hopkins SJ. The pathophysiological role of cytokines. Leg Med 2003, 5 (Suppl 1): S45-S57.
91. Gray PW, Barrett K, Chantry D, et al. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci USA 1990, 87: 7380-7384.
92. Nawashiro H, Martin D, Hallenbeck JM, et al. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 1997, 778: 265-271.
93. Mathiesen T, Edner G, Ulfarsson E, et al. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997, 87: 215-220.
94. Gillis S, Williams DE. Cytokine therapy: lessons learned and future challenges. Curr Opin Immunol 1998, 10: 501-503.
95. Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute phase response in interleukin-1beta-deficient mice. Immunity 1995, 3: 9-19.
96. Anttila HSI, Reitamo S, Erkko P, et al. Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal-cells: variability of epitope exposure in immunohistochemistry. J Invest Dermatol 1990, 95: 31-38.
97. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993, 54: 167-227.
98. Schall TJ, O'hehir RE, Goeddel DV, et al. Uncoupling of cytokine messenger RNA expression and protein secretion during the induction phase of T-cell anergy. J Immunol 1992, 148: 381-387.
99. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischemia. J Neuroimmunol 1999, 100: 203-215.
100. Arvin B, Neville LF, Barone FC, et al. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996, 20: 445-452.
101. Oprica M, Van Dam AM, Lundkvist J, et al. Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (Berl), 2004, 108: 69-80.
102. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 1999, 100: 203-215.
103. Hope JC, Campbell F, Hopkins SJ. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response. Eur J Immunol 2000, 30: 197-203.
104. Bongioanni P, Castagna R, Sposito R, et al. Interleukin-6 and modulation of apoptosis in the human central nervous system: an immunohistochemical study in neurodegenerative disease. Brain Pathol 1997, 7: 12-18.
105. Guix FX, Uribesalgo I, Coma M, et al. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 2005, 76: 126-152.
106. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 2005, 37: 17-21.
107. Schroeter M, Schiene K, Kraemer M, et al. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain Res 1995, 106: 1-6.
108. Schroeter M, Jander S, Witte OW, et al. Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience 1999, 89: 1367-1377.
109. Zheng Z, Lee JE, Yenari MA. Stroke: molecular mechanisms and potential targets for treatment. Curr Mol Med 2003, 3: 361-372.
110. Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 2004, 26: 884-892.
111. Qin ZH, Wang Y, Chen RW, et al. Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum. J Pharmacol Exp Ther, 2001, 297: 78-87.
112. Zhang HL, Huang ZH, Zhu Y, et al. Neuroprotective effects of prostaglandin A, in animal models of focal ischemia. Brain Res 2005, 1039: 203-206.